Table 5. Formulary Status of Agents for Type II HIT
|
Agent
|
Formulary
type
|
Daily
Cost*
|
|
Lepirudin
|
Formulary
|
$590
|
|
Argatroban
|
Formulary
|
$475
|
|
Danaparoid
|
Nonformulary
|
$735
|
|
Bivalirudin
|
Formulary-restricted
to cardiac catheterization lab for patients who have a heparin allergy
|
--
|
*For 70 kg patient with normal renal and hepatic function
Click Here to Return to Article